
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5738984
[patent_doc_number] => 20060009375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Site-specific drug delivery'
[patent_app_type] => utility
[patent_app_number] => 11/116943
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16799
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009375.pdf
[firstpage_image] =>[orig_patent_app_number] => 11116943
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/116943 | Site-specific drug delivery | Apr 26, 2005 | Abandoned |
Array
(
[id] => 6931225
[patent_doc_number] => 20050282260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Polypeptides and biosynthetic pathways for the production of monatin and its precursors'
[patent_app_type] => utility
[patent_app_number] => 11/114922
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 45531
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282260.pdf
[firstpage_image] =>[orig_patent_app_number] => 11114922
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/114922 | Polypeptides and biosynthetic pathways for the production of monatin and its precursors | Apr 25, 2005 | Issued |
Array
(
[id] => 4840599
[patent_doc_number] => 20080281085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Methods And Kits For Folding Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/587267
[patent_app_country] => US
[patent_app_date] => 2005-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13884
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20080281085.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587267
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587267 | Methods and kits for folding proteins | Apr 24, 2005 | Issued |
Array
(
[id] => 5125528
[patent_doc_number] => 20070237799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Osteogenic Composite Matrix, Method for the Production Thereof and Implant and Scaffold for Tissue Engineering Provided with a Coating Formed by Said Osteogenic Composite matrix'
[patent_app_type] => utility
[patent_app_number] => 11/578607
[patent_app_country] => US
[patent_app_date] => 2005-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4910
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237799.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578607
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578607 | Osteogenic Composite Matrix, Method for the Production Thereof and Implant and Scaffold for Tissue Engineering Provided with a Coating Formed by Said Osteogenic Composite matrix | Apr 14, 2005 | Abandoned |
Array
(
[id] => 853003
[patent_doc_number] => 07378387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-27
[patent_title] => 'Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes'
[patent_app_type] => utility
[patent_app_number] => 11/097146
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21874
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/378/07378387.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097146
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097146 | Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes | Apr 3, 2005 | Issued |
Array
(
[id] => 4859021
[patent_doc_number] => 20080267871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide'
[patent_app_type] => utility
[patent_app_number] => 10/599479
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6427
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599479
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599479 | Cardioinhibitory/antihypertensive novel endogenous physiologically active peptide | Mar 31, 2005 | Issued |
Array
(
[id] => 202950
[patent_doc_number] => 07632917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-15
[patent_title] => 'Methods for identifying inhibitors of botulinum neurotoxins'
[patent_app_type] => utility
[patent_app_number] => 11/095055
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7770
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632917.pdf
[firstpage_image] =>[orig_patent_app_number] => 11095055
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/095055 | Methods for identifying inhibitors of botulinum neurotoxins | Mar 30, 2005 | Issued |
Array
(
[id] => 572433
[patent_doc_number] => 07459290
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-12-02
[patent_title] => 'Methods of using functional 30S subunits'
[patent_app_type] => utility
[patent_app_number] => 11/094770
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 26079
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/459/07459290.pdf
[firstpage_image] =>[orig_patent_app_number] => 11094770
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/094770 | Methods of using functional 30S subunits | Mar 29, 2005 | Issued |
Array
(
[id] => 4561034
[patent_doc_number] => 07838630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-23
[patent_title] => 'Biologic replacement for fibrin clot'
[patent_app_type] => utility
[patent_app_number] => 11/092992
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 36
[patent_no_of_words] => 34645
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/838/07838630.pdf
[firstpage_image] =>[orig_patent_app_number] => 11092992
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/092992 | Biologic replacement for fibrin clot | Mar 28, 2005 | Issued |
Array
(
[id] => 7050768
[patent_doc_number] => 20050186655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Preparation containing cell extracts for cell-free protein synthesis and means for synthesizing protein using the preparation'
[patent_app_type] => utility
[patent_app_number] => 11/089652
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9927
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186655.pdf
[firstpage_image] =>[orig_patent_app_number] => 11089652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/089652 | Preparation containing cell extracts for cell-free protein synthesis and means for synthesizing protein using the preparation | Mar 24, 2005 | Issued |
Array
(
[id] => 554418
[patent_doc_number] => 07470379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-30
[patent_title] => 'Inorganic particle conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/080946
[patent_app_country] => US
[patent_app_date] => 2005-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 11275
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/470/07470379.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080946
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080946 | Inorganic particle conjugates | Mar 15, 2005 | Issued |
Array
(
[id] => 418559
[patent_doc_number] => 07276228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase'
[patent_app_type] => utility
[patent_app_number] => 11/082130
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 11933
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276228.pdf
[firstpage_image] =>[orig_patent_app_number] => 11082130
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/082130 | Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase | Mar 14, 2005 | Issued |
Array
(
[id] => 4504587
[patent_doc_number] => 07914771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-29
[patent_title] => 'Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/077276
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17133
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/914/07914771.pdf
[firstpage_image] =>[orig_patent_app_number] => 11077276
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/077276 | Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor | Mar 8, 2005 | Issued |
Array
(
[id] => 6925413
[patent_doc_number] => 20050238668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Media for clostridium bacterium and processes for obtaining a clostridial toxin'
[patent_app_type] => utility
[patent_app_number] => 11/072050
[patent_app_country] => US
[patent_app_date] => 2005-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14382
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238668.pdf
[firstpage_image] =>[orig_patent_app_number] => 11072050
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/072050 | Media for clostridium bacterium and processes for obtaining a clostridial toxin | Mar 2, 2005 | Issued |
Array
(
[id] => 638008
[patent_doc_number] => 07125963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-24
[patent_title] => 'Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions'
[patent_app_type] => utility
[patent_app_number] => 11/072054
[patent_app_country] => US
[patent_app_date] => 2005-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 23082
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11072054
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/072054 | Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions | Mar 2, 2005 | Issued |
Array
(
[id] => 879507
[patent_doc_number] => 07354740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Animal product free system and process for purifying a botulinum toxin'
[patent_app_type] => utility
[patent_app_number] => 11/072673
[patent_app_country] => US
[patent_app_date] => 2005-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 25201
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/354/07354740.pdf
[firstpage_image] =>[orig_patent_app_number] => 11072673
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/072673 | Animal product free system and process for purifying a botulinum toxin | Mar 2, 2005 | Issued |
Array
(
[id] => 903327
[patent_doc_number] => 07335645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Effectors of dipeptidyl peptidase IV for topical use'
[patent_app_type] => utility
[patent_app_number] => 11/069926
[patent_app_country] => US
[patent_app_date] => 2005-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6774
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335645.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069926
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069926 | Effectors of dipeptidyl peptidase IV for topical use | Feb 28, 2005 | Issued |
Array
(
[id] => 7135976
[patent_doc_number] => 20050180995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => ' Method to Improve Grafted Hair Growth And Retain Grafted Hair'
[patent_app_type] => utility
[patent_app_number] => 10/906321
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2059
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20050180995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10906321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/906321 | Method to Improve Grafted Hair Growth And Retain Grafted Hair | Feb 13, 2005 | Abandoned |
Array
(
[id] => 7168500
[patent_doc_number] => 20050202047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Methods of treating abnormalities of the first metatarsophalangeal joint of the foot'
[patent_app_type] => utility
[patent_app_number] => 11/056382
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3554
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202047.pdf
[firstpage_image] =>[orig_patent_app_number] => 11056382
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/056382 | Methods of treating abnormalities of the first metatarsophalangeal joint of the foot | Feb 10, 2005 | Issued |
Array
(
[id] => 377095
[patent_doc_number] => 07312195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-25
[patent_title] => 'Cyclised conotoxin peptides'
[patent_app_type] => utility
[patent_app_number] => 11/052168
[patent_app_country] => US
[patent_app_date] => 2005-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16260
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/312/07312195.pdf
[firstpage_image] =>[orig_patent_app_number] => 11052168
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/052168 | Cyclised conotoxin peptides | Feb 6, 2005 | Issued |